MR308

· Mundipharma Research GmbH & Co KG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MR308, covering 2018-09-20 to 2018-09-20. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety in a Randomised Acute Pain Study of MR308: STARDOM2. [Phase 3]